JOURNAL OF MOLECULAR DIAGNOSTICS

Scope & Guideline

Pioneering the future of pathology through molecular innovation.

Introduction

Welcome to the JOURNAL OF MOLECULAR DIAGNOSTICS information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of JOURNAL OF MOLECULAR DIAGNOSTICS, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1525-1578
PublisherELSEVIER SCIENCE INC
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 1999 to 2024
AbbreviationJ MOL DIAGN / J. Mol. Diagn.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressSTE 800, 230 PARK AVE, NEW YORK, NY 10169

Aims and Scopes

The Journal of Molecular Diagnostics focuses on advancing the field of molecular diagnostics through innovative research and clinical applications. The journal emphasizes the integration of molecular biology techniques with diagnostic methods to improve disease detection, prognosis, and treatment strategies.
  1. Molecular Diagnostic Techniques:
    The journal extensively covers various molecular diagnostic techniques, including next-generation sequencing (NGS), polymerase chain reaction (PCR), and digital droplet PCR, highlighting their applications in clinical settings.
  2. Cancer Genomics:
    A significant focus on cancer genomics is evident, with research aimed at identifying genetic alterations in tumors, understanding tumor heterogeneity, and developing targeted therapies based on genomic profiles.
  3. Clinical Utility of Molecular Testing:
    Emphasis on the clinical utility of molecular testing for various conditions, including cancer, infectious diseases, and genetic disorders, to enhance patient management and treatment outcomes.
  4. Consensus Guidelines and Recommendations:
    The journal publishes consensus guidelines and recommendations from leading professional societies to standardize molecular diagnostic practices and ensure high-quality laboratory results.
  5. Innovative Biomarker Discovery:
    Research on discovering novel biomarkers for early disease detection and monitoring, particularly in oncology and hereditary conditions, is a core aspect of the journal's scope.
The Journal of Molecular Diagnostics has seen a rise in several trending and emerging themes that reflect advancements in technology and shifts in clinical practice. These themes indicate the journal's commitment to addressing contemporary challenges in molecular diagnostics.
  1. Liquid Biopsy Technologies:
    Research on liquid biopsy technologies, particularly for cancer diagnostics and monitoring, is rapidly increasing, showcasing the potential for non-invasive testing methods to provide critical insights into tumor dynamics.
  2. Integration of Artificial Intelligence:
    The application of artificial intelligence and machine learning in analyzing genomic data and improving diagnostic accuracy is gaining traction, with numerous studies exploring innovative computational approaches.
  3. Pharmacogenomics:
    Increasing attention is being directed toward pharmacogenomics, with studies focusing on how genetic variations affect drug response, aiming to personalize treatment strategies for better outcomes.
  4. Microbiome Research:
    Emerging research on the human microbiome's role in health and disease, particularly its impact on cancer and infectious diseases, is becoming a key area of exploration within the journal.
  5. Molecular Pathology and Personalized Medicine:
    There is a growing trend toward integrating molecular pathology into personalized medicine frameworks, with research aimed at tailoring treatments based on individual genetic profiles and tumor characteristics.

Declining or Waning

While the Journal of Molecular Diagnostics remains robust in its primary areas, certain themes have shown a decline in prominence over recent years. This may reflect shifts in research funding, clinical practice, or emerging technologies.
  1. Traditional Cytogenetics:
    There is a noticeable decline in publications focused on traditional cytogenetic methods, such as karyotyping and fluorescence in situ hybridization (FISH), as molecular techniques like NGS become the preferred approach for genomic analysis.
  2. Basic Molecular Biology Techniques:
    Basic molecular biology techniques, such as Sanger sequencing and conventional PCR, are being overshadowed by high-throughput and more sensitive methods, leading to fewer publications in these areas.
  3. Single-Condition Focus Studies:
    Research that focuses solely on single conditions without exploring broader implications or multi-condition approaches is becoming less common, as the trend shifts toward integrative and multi-faceted studies.
  4. Non-Clinical Applications of Diagnostics:
    There is a waning interest in the applications of molecular diagnostics outside clinical settings, such as environmental monitoring or food safety, as the journal increasingly centers on clinical relevance and patient care.

Similar Journals

JOURNAL OF CLINICAL LABORATORY ANALYSIS

Transforming research into real-world laboratory solutions.
Publisher: WILEYISSN: 0887-8013Frequency: 9 issues/year

JOURNAL OF CLINICAL LABORATORY ANALYSIS is a premier, peer-reviewed journal published by WILEY, focusing on the expansive field of laboratory medicine. With its ISSN 0887-8013 and E-ISSN 1098-2825, this open access journal has been serving the scientific community since 1987. As of 2023, it holds a notable impact in various domains, achieving category quartiles in Biochemistry, Clinical Biochemistry, Hematology, and more, showcasing its significance across multiple disciplines such as Medical Laboratory Technology and Public Health. Ranked impressively, it is placed 7th in Medical Laboratory Technology, reflecting its crucial role in advancing clinical practice and research. The journal aims to disseminate innovative research findings, methodologies, and reviews that can catalyze advancements in laboratory practices and improve patient outcomes. Accessible to a global audience since its transition to open access in 2019, the journal is not just limited to professionals but is also a valuable resource for students and researchers seeking to stay updated in this dynamic field. For more information, visit the journal's website.

Annual Review of Pathology-Mechanisms of Disease

Exploring the Frontiers of Pathological Research
Publisher: ANNUAL REVIEWSISSN: 1553-4006Frequency: 1 issue/year

Annual Review of Pathology: Mechanisms of Disease is a premier scholarly journal published by ANNUAL REVIEWS that systematically reviews significant advancements in the field of pathology and the mechanisms underpinning various diseases. With an ISSN of 1553-4006 and an E-ISSN of 1553-4014, the journal has established its importance within the academic community, evidenced by its prestigious Q1 rankings in several categories including medicine, pathology, forensic medicine, and plant science for 2023. Notably, it ranks #1 out of 208 in the pathology and forensic medicine category, placing it in the 99th percentile according to Scopus metrics. Although not an open-access journal, it offers crucial insights to researchers, professionals, and students alike by providing a comprehensive understanding of pathophysiological concepts and emerging trends. The journal continues to be an essential resource for those dedicated to advancing research and practical applications in disease mechanisms.

JOURNAL OF BIOMEDICAL SCIENCE

Transforming discoveries into impactful biomedical advancements.
Publisher: BMCISSN: 1021-7770Frequency: 1 issue/year

JOURNAL OF BIOMEDICAL SCIENCE, published by BMC, is a premier Open Access journal dedicated to the rapid dissemination of research in the fields of biomedical science, encompassing crucial areas such as biochemistry, cell biology, clinical biochemistry, and more. Since its inception in 1993, the journal has established itself as a leading publication, currently boasting a remarkable impact factor and quality as evidenced by its Q1 quartile rankings across multiple categories in 2023. With an impressive track record, including a Scopus ranking in the top percentiles across several disciplines, it serves as a vital resource for researchers, professionals, and students who are keen on advancing their knowledge in biomedicine. The journal operates under a fully Open Access model, ensuring that all published articles are freely available to the global research community, thus contributing to the broader dissemination and accessibility of scientific knowledge. Based in the United Kingdom, JOURNAL OF BIOMEDICAL SCIENCE is committed to fostering innovation and collaboration in research, appealing to those aiming to make impactful contributions to the biomedical sphere.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Catalyzing Innovations in Pathology and Forensic Medicine
Publisher: OXFORD UNIV PRESS INCISSN: 0002-9173Frequency: 12 issues/year

The American Journal of Clinical Pathology, published by Oxford University Press Inc, stands as a vital resource in the fields of pathology and clinical medicine. With a rich history dating back to 1945 and an impressive impact factor reflected in its Q1 ranking in Pathology and Forensic Medicine, this journal serves as a cornerstone for researchers and professionals seeking to advance their knowledge and practice. Covering a breadth of topics within the discipline, it is recognized in 2023 as ranked #24 out of 208 in its category, highlighting its esteemed reputation within the scientific community. Although the journal does not currently offer open access, its rigorous peer-reviewed articles and cutting-edge research make it an essential addition to any academic or clinical library. The ISSN for print version is 0002-9173, with an E-ISSN of 1943-7722 available for digital access. Researchers, students, and practitioners alike will benefit from its comprehensive scope and commitment to disseminating high-quality scientific inquiry.

JOURNAL OF CLINICAL PATHOLOGY

Innovating Pathology for Better Health Outcomes
Publisher: BMJ PUBLISHING GROUPISSN: 0021-9746Frequency: 12 issues/year

JOURNAL OF CLINICAL PATHOLOGY, published by BMJ PUBLISHING GROUP, stands at the forefront of advancements in the field of clinical pathology, offering a platform for groundbreaking research and insights from 1948 to the present. With an impressive impact factor and categorized as Q1 in both Medicine (miscellaneous) and Pathology and Forensic Medicine for 2023, the journal holds a distinguished position in the academic community, ranking 22nd out of 208 journals in its category on Scopus and representing the 89th percentile. While the journal does not currently offer open access, it remains a vital resource for researchers, healthcare professionals, and students seeking to stay current with innovative methodologies, clinical techniques, and diagnostic advancements. Located in London, United Kingdom, the journal aims to bridge the gap between laboratory findings and clinical practice, emphasizing the importance of evidence-based pathology in improving patient care and treatment outcomes. Engage with the JOURNAL OF CLINICAL PATHOLOGY to enhance your understanding and contribute to the evolving landscape of clinical pathology research.

Fetal and Pediatric Pathology

Exploring the complexities of fetal and pediatric pathology.
Publisher: TAYLOR & FRANCIS INCISSN: 1551-3815Frequency: 6 issues/year

Fetal and Pediatric Pathology, an esteemed journal published by TAYLOR & FRANCIS INC, is dedicated to advancing the field of pediatric and fetal medicine through the dissemination of high-quality research and clinical insights. With an ISSN of 1551-3815 and an E-ISSN of 1551-3823, the journal has been a key resource for researchers and practitioners since its inception in 1983. Based in the United Kingdom, it covers a broad spectrum of topics relevant to Medicine, Pathology and Forensic Medicine, and Pediatrics, Perinatology, and Child Health, consistently reflecting on contemporary challenges faced in these fields. The journal has attained a commendable Q3 ranking within its categories as of 2023, underlining its relevance in the academic community. Though not an open-access publication, the research presented in Fetal and Pediatric Pathology plays a pivotal role in informing practice, guiding future studies, and enhancing the understanding of diseases affecting fetuses and children. Its convergence of research throughout multiple years, continuing until 2024, marks it as a crucial platform for ongoing scientific dialogue and innovation, aimed at fostering better health outcomes for younger populations.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Innovating Pathways in Neuropathology Research
Publisher: OXFORD UNIV PRESS INCISSN: 0022-3069Frequency: 12 issues/year

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, published by Oxford University Press Inc, stands as a pivotal resource for advancing research and knowledge in the domains of neuropathology and experimental neurology. Established in 1942, this esteemed journal has expanded its influence, as evidenced by its Q1 rankings in both Neurology (clinical) and Pathology and Forensic Medicine, along with its strong placement in Cellular and Molecular Neuroscience. With an emphasis on innovative research and clinical practices, it caters to a diverse audience, including researchers and clinicians dedicated to understanding neurological disorders through a multidisciplinary lens. While not open access, this journal provides access to cutting-edge studies that are pivotal in shaping the future of medical science and pathology. Researchers benefit from its rigorous peer-review process, ensuring the publication of high-caliber work that meets the evolving demands of the field.

PATHOLOGY & ONCOLOGY RESEARCH

Pioneering Discoveries in Pathology and Oncology
Publisher: FRONTIERS MEDIA SAISSN: 1219-4956Frequency: 1 issue/year

PATHOLOGY & ONCOLOGY RESEARCH is a prominent international journal published by FRONTIERS MEDIA SA, dedicated to advancing the fields of pathology and oncology. Operating from the Netherlands, with a distinguished address in Switzerland, this journal plays a crucial role in disseminating significant research findings and insights from 1995 to 2024. With an ISSN of 1219-4956 and E-ISSN of 1532-2807, it is indexed in well-respected databases, facilitating access to a global audience of researchers and practitioners. Notably, the journal ranks in the Q3 category for Cancer Research (2023), while being recognized in the Q2 categories for both Medicine (Miscellaneous), Oncology, and Pathology and Forensic Medicine, reflecting its authoritative status in these vital disciplines. Scopus rankings further highlight its influence, with notable percentiles across various fields. Although it follows a subscription model, the journal remains committed to publishing high-quality, peer-reviewed research that bridges conceptual gaps and encourages further exploration in oncology and diagnostic pathology, making it an indispensable resource for academics and professionals engaged in these critical areas of medicine.

Molecular Genetics & Genomic Medicine

Empowering the future of genomic medicine.
Publisher: WILEYISSN: 2324-9269Frequency: 12 issues/year

Molecular Genetics & Genomic Medicine, published by WILEY, is an esteemed and open-access journal that has been a prominent source of knowledge in the fields of genetics and molecular biology since its establishment in 2013. With an ISSN of 2324-9269, it aims to provide a platform for the dissemination of novel findings and innovative research that pushes the boundaries of genomics and its clinical applications. The journal holds a Q3 categorization in Genetics, Clinical Genetics, and Molecular Biology, reflecting its growing influence in these disciplines, as evidenced by its Scopus rankings. Researchers, professionals, and students alike will find valuable insights and advancements in genomic medicine, making this journal an essential resource for those dedicated to the understanding and application of genetic and molecular research in healthcare. Located at 111 River St, Hoboken, NJ, Molecular Genetics & Genomic Medicine continues to foster a global dialogue within the scientific community, ensuring accessible knowledge for all.

ADVANCES IN ANATOMIC PATHOLOGY

Pioneering Discoveries in Anatomical Pathology.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1072-4109Frequency: 6 issues/year

ADVANCES IN ANATOMIC PATHOLOGY is a leading peer-reviewed journal dedicated to the field of anatomical pathology, published by LIPPINCOTT WILLIAMS & WILKINS. With an impressive impact factor and consistent ranking in the Q1 category for both Anatomy and Pathology and Forensic Medicine, it serves as an essential resource for researchers, clinicians, and students alike. The journal has been a critical platform for disseminating significant findings and advancements in the discipline since its inception in 1996, boasting Scopus rankings of #1 in Anatomy and #11 in Pathology. While it does not provide open access, it maintains rigorous standards in the selection of articles, ensuring that published research reflects the latest developments and techniques in the field. As we look toward 2024 and beyond, ADVANCES IN ANATOMIC PATHOLOGY remains committed to advancing the science of pathology, fostering innovation, and enhancing clinical practice through impactful research.